Skip to main content

Day: December 2, 2022

Machine Tools Market to Generate Revenue of $114.43 Billion by 2028 | China and India are Well-Positioned to Benefit Thanks to Rapid Expansion of Automotive and Aerospace Industry

Global machine tools market size was valued at USD 77.12 billion in 2021, and it is expected to reach a value of USD 114.43 billion by 2028, at a CAGR of 5.8% over the forecast period (2022–2028). Westford, USA, Dec. 02, 2022 (GLOBE NEWSWIRE) — Global machine tools market is expected to grow at a moderate pace in the next seven years. SkyQuest’s analysis shows that the market will be driven by demand from end-use industries, such as automotive and aerospace. In addition, growth in emerging markets is expected to support the market’s expansion. we expect that the Asia-Pacific region will experience the highest growth in the market, due to robust economic activity and rising manufacturing output in countries such as China and India. North America and Europe are also expected to see modest growth, while Latin America and...

Continue reading

Nasdaq Iceland Approves the Request for Trading of Alvotech’s Shares on the Main Market

Nasdaq Iceland has approved Alvotech S.A’s (“Alvotech”) request for admission to trading of its shares on the Nasdaq Iceland Main Market (“Main Market”). Alvotech’s shares will be admitted to trading on the Main Market following the passporting of Alvotech’s prospectus to Iceland. Alvotech’s shares will be delisted from the Nasdaq Iceland First North Market after market closing, on the day preceding the first day of trading of the shares on the Main Market. Alvotech’s shares have been listed on the Nasdaq Stock Market in the US since June 16, 2022 and on the Nasdaq First North Growth Market in Iceland since June 23, 2022 under the ticker symbol “ALVO”. On the Main Market, Alvotech’s shares will also be listed under the ticker symbol “ALVO”. On August 12, 2022 Alvotech announced that the Board of Directors had approved a plan to transfer...

Continue reading

SUPERIOR GROUP OF COMPANIES TO PARTICIPATE IN THE SIDOTI DECEMBER VIRTUAL INVESTOR CONFERENCE

SEMINOLE, Fla., Dec. 02, 2022 (GLOBE NEWSWIRE) — Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that Michael Benstock, Chief Executive Officer, Andrew Demott, Chief Operating Officer, and Michael Koempel, Chief Financial Officer, will participate in the Sidoti December Virtual Investor Conference on Thursday, December 8, 2022. Management will participate in a fireside chat on Thursday, December 8, 2022 at 11:30 a.m. Eastern Time. The webcast will be available on the investor relations presentations page of the company’s website at https://ir.superiorgroupofcompanies.com/presentations. Management will also host virtual one-on-one and small group meetings throughout the day. About Superior Group of Companies, Inc. (SGC):Superior Group of Companies™, established in 1920, is a combination of companies...

Continue reading

Global Avionics Market to Hit Sales of $98.41 Billion By 2028 | Honeywell is Well Positioned to Capitalize on Market Growth

Global avionics market was valued at USD 69.47 billion in 2021 and it is expected to grow to USD 98.41 billion by 2028 at a CAGR of 5.1% over the forecast period (2022–2028). Westford, USA, Dec. 02, 2022 (GLOBE NEWSWIRE) — As the capabilities of commercial and military aircraft continue to grow, so does the demand for avionics market. Today’s aircraft are equipped with a variety of advanced systems that allow them to fly safely and efficiently in all kinds of conditions. From navigation and communication systems to weather radar and flight management systems, avionics play a vital role in keeping aircraft safe and efficient. As the demand for new and improved avionics continues to grow, manufacturers are rising to the challenge, developing ever more sophisticated systems to meet the needs of the market. With the global avionics...

Continue reading

Heat Exchangers Market to Offer Revenue Opportunity of $26.82 Billion by 2028 | Top 10 Players Accounting for Less Than 30% of the Market Value

Global heat exchangers market was valued at USD 17.72 billion in 2021, and it is expected to reach a value of USD 26.82 billion by 2028, at a CAGR of 6.10% over the forecast period (2022–2028). Westford, USA, Dec. 02, 2022 (GLOBE NEWSWIRE) — As the world economy continues to grow, the demand for heat exchangers market is also growing. Heat exchangers are used in a variety of industries, including power generation, chemical processing, and HVACR (heating, ventilation, air conditioning, and refrigeration).  There are various types of heat exchangers available in the market like shell and tube type, plate type, air-cooled type etc. The most commonly used type of heat exchanger is shell and tube type. There are several reasons for the growing demand for heat exchangers market. First, as the world economy grows, so does the demand for...

Continue reading

Confectionery Market to Touch Valuation of $392.78 Billion by 2028 | Chocolate Generates Over 58% Market Revenue

Global confectionery market was valued at USD 294.5 billion in 2021, and it is expected to reach a value of USD 392.78 billion by 2028, at a CAGR of 4.2% over the forecast period (2022-2028). Westford, USA, Dec. 02, 2022 (GLOBE NEWSWIRE) — SkyQuest’s analysis of the confectionery market provides some interesting insights into the current state of the market. It seems that while chocolate is still the most popular type of confection, there is a growing trend for alternative products such as candy and gum. This is likely due to the increasing health consciousness of consumers, who are looking for healthier options that still satisfy their sweet tooth. Interestingly, it was found that while kids remain the biggest fans of sweets, teens and adults are also increasingly indulging in sugary treats. This could be due to the fact...

Continue reading

Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022)

Preclinical data demonstrate potential efficacy and safety of OV329 at low, chronic dosing, suggesting an improved profile compared to other GABA-aminotransferase inhibitorsData from the NIH/NINDs Epilepsy Therapy Screening Program demonstrate that OV329 confers protection from seizure activity in several treatment-resistant animal modelsNew preclinical data on OV350 underscore the potential of activating the KCC2 to alleviate refractory status epilepticus and limit neuronal damageNEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed to conquer epilepsies and meaningfully improve the lives of people affected by brain disorders, today announced that preclinical data supporting its OV329 and OV350 programs in epilepsy and treatment-resistant...

Continue reading

Verizon helps L.A. Comic Con attendees get their game on

Verizon unlocks exciting video game experiences for Los Angeles Comic Con attendees from Dec. 2-4 NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) — Verizon will be participating in this year’s Los Angeles Comic Con, with a booth at the Gaming Stage within the Los Angeles Convention Center. Throughout the three-day event, pop culture and gaming fans have the opportunity to score in-game items for the world’s most-played PC game, League of Legends. Attendees can visit the Verizon booth to earn a card containing a download code for a League of Legends Masterwork Chest and Key. After redeeming, players can unlock the Masterwork Chest and possibly gain valuable loot, such as new champions, epic skins and other items. Developed by Riot Games, League of Legends, commonly known as League, is a competitive 5v5 multiplayer online battle...

Continue reading

Correction: Form 8.3 – Horizon Therapeutics plc

                        FORM 8.3   IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE   1. KEY INFORMATION  Name of person dealing (Note 1) State Street Global Advisors & AffiliatesCompany dealt in Horizon Therapeutics plcClass of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 ordinary sharesDate of dealing 30th Nov 2022       2. INTERESTS AND SHORT POSITIONS   (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)    Long Short  Number (%) Number (%)(1) Relevant securities 5,974,957 2.63582%    (2) Derivatives (other than options) 508 0.000224%    (3) Options and agreements to purchase/sell N/A N/A    Total 5,975,465 2.63605%        (b)...

Continue reading

JBS USA Enters Agreement to Acquire Certain Assets From TriOak Foods

Agreement Cements Longstanding Exclusive Partnership GREELEY, Colo., Dec. 02, 2022 (GLOBE NEWSWIRE) — JBS USA, a leading global food company, announced it has reached an agreement to acquire certain assets from TriOak Foods, a Midwest-based pork producer, for an undisclosed amount. The two companies enjoy a long-standing business relationship, with JBS USA serving as the exclusive customer of TriOak market hogs since 2017. A family operation established in 1951, TriOak Foods includes live pork production, grain merchandising and fertilizer marketing. Agricultural real estate assets in Iowa are not included in the transaction. A leader in on-farm sustainability, TriOak Foods hog farms include multiple open pen gestation facilities and farms compliant with California’s Proposition 12 rule. “Today’s announcement is aligned with our...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.